BG103115A - Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety - Google Patents

Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Info

Publication number
BG103115A
BG103115A BG103115A BG10311599A BG103115A BG 103115 A BG103115 A BG 103115A BG 103115 A BG103115 A BG 103115A BG 10311599 A BG10311599 A BG 10311599A BG 103115 A BG103115 A BG 103115A
Authority
BG
Bulgaria
Prior art keywords
steroids
strimulators
syptoms
syndrom
neurochemical
Prior art date
Application number
BG103115A
Other languages
Bulgarian (bg)
English (en)
Inventor
Clive Jennings-White
David Berliner
Nathan Adams
Luis Bloch-Monti
Original Assignee
Pherin Pharmaceuticals, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,092 external-priority patent/US6057439A/en
Application filed by Pherin Pharmaceuticals, Inc filed Critical Pherin Pharmaceuticals, Inc
Publication of BG103115A publication Critical patent/BG103115A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG103115A 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety BG103115A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/686,092 US6057439A (en) 1994-08-04 1996-07-23 Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US72586296A 1996-10-04 1996-10-04
PCT/US1997/013035 WO1998003207A1 (fr) 1996-07-23 1997-07-23 Steroides utilises en qualite de stimulateurs neurochimiques de l'organe vomero-nasal et permettant de soulager les symptomes premenstruel et de l'anxiete

Publications (1)

Publication Number Publication Date
BG103115A true BG103115A (en) 1999-09-30

Family

ID=27103741

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103115A BG103115A (en) 1996-07-23 1999-01-25 Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety

Country Status (15)

Country Link
EP (1) EP0914165B1 (fr)
JP (1) JP4450435B2 (fr)
KR (1) KR20000067970A (fr)
CN (1) CN1226837A (fr)
AT (1) ATE342721T1 (fr)
AU (1) AU726625B2 (fr)
BG (1) BG103115A (fr)
BR (1) BR9711812A (fr)
CA (1) CA2260253A1 (fr)
DE (1) DE69736833T2 (fr)
ES (1) ES2273374T3 (fr)
NO (1) NO990305L (fr)
NZ (1) NZ333671A (fr)
PL (1) PL331357A1 (fr)
WO (1) WO1998003207A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
US6555531B1 (en) 1999-12-30 2003-04-29 Pherin Pharmaceuticals, Inc. Weight promoting composition, method, and product
US8309539B2 (en) 2005-09-09 2012-11-13 Pherin Pharmaceuticals, Inc. Acute treatment of social phobia
US20090258040A1 (en) * 2008-04-09 2009-10-15 Pherin Pharmaceuticals, Inc. Steroid treatment for hot flashes
ES2625778T3 (es) * 2012-12-28 2017-07-20 Pherin Pharmaceuticals, Inc. Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos
EP3955933B1 (fr) * 2019-04-15 2023-11-29 Vistagen Therapeutics, Inc. Traitement de la migraine
WO2021080880A1 (fr) * 2019-10-25 2021-04-29 Covey Douglas Agents inhibiteurs de nmdar et agents de potentialisation gabaar et leurs utilisations
CN112608358A (zh) * 2020-12-29 2021-04-06 北京大学 一种促进花粉萌发的化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
WO1994028904A1 (fr) * 1993-06-15 1994-12-22 Pherin Corporation Steroides d'androstane utilises en tant qu'initiateurs neurochimiques de modification de la fonction hypothalamique humaine, compositions pharmaceutiques et procedes associes
ATE253365T1 (de) * 1993-06-15 2003-11-15 Pherin Pharm Inc Estrensteroide als neurochemische initiatoren einer veränderung der hypothalmusfunktion beim menschen und verwandte pharmazeutische präparate
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
CA2199044A1 (fr) * 1994-09-29 1996-04-04 Pherin Corporation Nouveaux estrenes exercant une action sur l'hypothalamus
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Also Published As

Publication number Publication date
KR20000067970A (ko) 2000-11-25
EP0914165B1 (fr) 2006-10-18
EP0914165A4 (fr) 2004-01-21
NO990305L (no) 1999-03-22
JP2000513000A (ja) 2000-10-03
DE69736833T2 (de) 2007-05-24
AU3963797A (en) 1998-02-10
DE69736833D1 (de) 2006-11-30
CA2260253A1 (fr) 1998-01-29
PL331357A1 (en) 1999-07-05
EP0914165A1 (fr) 1999-05-12
WO1998003207A1 (fr) 1998-01-29
ATE342721T1 (de) 2006-11-15
BR9711812A (pt) 1999-08-24
NO990305D0 (no) 1999-01-22
NZ333671A (en) 2000-07-28
CN1226837A (zh) 1999-08-25
JP4450435B2 (ja) 2010-04-14
ES2273374T3 (es) 2007-05-01
AU726625B2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
IL134773A (en) Use for budesonide and formoterol
DE69432990D1 (de) PROGESTAGEN-FREIE FORMULIERUNGEN VON GnRH UND ESTROGEN ZUR BEHANDLUNG VON BENIGNEN GYNÄKOLOGISCHEN STÖRUNGEN
ATE241337T1 (de) Hautpflegemittel für gealterte haut
EP0870786A4 (fr) Caoutchouc dienique, processus de preparation et composition le contenant
BG103115A (en) Steroids as neurochemical strimulators of the vomeronasal organ for easing the syptoms of the premenstrual syndrom and anxiety
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
PL324970A1 (en) Method of and composition for treating asthma
ATE195530T1 (de) 17-ether und thioether von 4-aza-steroiden
DE69722223D1 (de) Textilweichspülmittelzusammensetzung und anwendungsmethode für die freisetzung von riechstoffderivaten
HUP0100568A3 (en) 11beta-halogen-7alpha-substituted estratrienes, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
DE69706225D1 (de) Verfahren zur Herstellung von Wasserstof und Sauerstoff
GR3036710T3 (en) Monofunctional and/or polyfunctional polylysine conjugates
EP0761239A4 (fr) Procede de desodorisation, desodorisant, procede d'elaboration du desodorisant, et equipement de desodorisation
BG103286A (en) Compositions and methods for ore dressing
BG103170A (en) Polymorphic form ii of finasteride and method for its preparation
HUP0000622A3 (en) Antiperspirant or deodorant composition and process for producing thereof
ZA96737B (en) Cosmetic compositions for reducing or preventing signs of cullulite
HUP0002716A3 (en) Perfumed one and two phase compositions for reducing body odor and methods of use thereof
AU4584901A (en) Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
AU5383298A (en) Compositions and methods for enhancement of dehydroepiandrosterone
EP0987030A4 (fr) Composition desodorisante, desodorisant et filtre contenant chacun ladite composition, et methode de desodorisation
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
BG103060A (en) 19-nor-holan steroids as neurochemical initiators of the change of the operation of the hypothalamus in human organism
CA2232433A1 (fr) Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux